Clinical trial
Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage…
NCT00336960 · Vanderbilt-Ingram Cancer Center, Other · Completed
Key facts
| NCT number | NCT00336960 |
|---|---|
| Title | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery |
| Official title | Phase II Pilot Study of Pre-Operative Celecoxib (Celebrex) in Combination With Prolonged Venous Infusion 5FU and Radiation Therapy for Patients With Stage II/III Resectable Rectal Cancer |
| Lead sponsor | Vanderbilt-Ingram Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug, Other, Procedure, Radiation |
| Interventions | celecoxib, fluorouracil, conventional surgery, radiation therapy, tumor biopsy, laboratory biomarker analysis |
| Enrollment | 24 |
| Start date | Jul 1, 2002 |
| Primary completion | Nov 1, 2004 |
| Completion | Mar 1, 2008 |
| First posted | Jun 15, 2006 |
| Last update posted | Mar 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: